Treatment-at-work service puts cancer patients at the centre of care

Providing innovative treatments to patients is central to the ethos of the Clatterbridge Cancer Centre NHS Foundation Trust. It is one of the UK's leading specialist centres, employing more than 350 registered nurses and treating more than 30 000 patients with solid tumours and blood cancer each year. In 2015, the hospital's chemotherapy directorate began providing treatment to patients in their homes, as part of its Clatterbridge in the Community team.

This service expanded in 2018 to include Treatment at Work, offering patients the opportunity to receive their chemotherapy treatment in their workplace. This service as the first of its kind in the UK, and was developed for patients receiving subcutaneous trastuzumab after some of them had to decline treatment at home because they were returning to work and needed specific appointment times. The service has so far been delivered across 10 workplaces (warehouses, offices, shops and cafes) in Cheshire, Merseyside and Lancashire.